Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration’s Adverse Event Reporting System Narratives

Similar Items

• Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
  by: Yankun Liang, et al.
  Published: (2023-10-01)
• Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
  by: Christine Learned, BA, et al.
  Published: (2022-06-01)
• Rheumatic and Musculoskeletal Adverse Events with Immune Checkpoint Inhibitors: Data from the United States Food and Drug Administration Adverse Event Reporting System
  by: Xerxes N Pundole, et al.
  Published: (2019-07-01)
• Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System
  by: Misa Naganuma, et al.
  Published: (2019-03-01)
• Antidepressants and cardiovascular adverse events: A narrative review
  by: Mohammad Hassan Nezafati, et al.
  Published: (2015-09-01)